2023
DOI: 10.1080/02648725.2023.2202531
|View full text |Cite
|
Sign up to set email alerts
|

Clinical effects of combined treatment of traditional Chinese medicine and western medicine for viral hepatitis B cirrhosis and the effects on serum miR-122, miR-200a

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 26 publications
0
1
0
Order By: Relevance
“…Additionally, the incidence of complications such as spontaneous bacterial peritonitis, hepatic encephalopathy, hepatorenal syndrome, gastrointestinal bleeding, and electrolyte imbalance was significantly lower in the combined treatment group. The authors concluded that integrating Chinese medicine and Western medicine in the treatment of cirrhosis can effectively reduce complications, improve clinical symptoms, and enhance clinical efficacy, making it worthy of further research and clinical application ( You et al, 2023 ). In another prospective randomized controlled trial on hepatitis B cirrhosis, it was found that the antiviral entecavir combined with Fuzheng Huayu tablets improved the biochemical response rate and showed trends towards improving HBeAg seroconversion and liver fibrosis rates, compared to the control group (entecavir plus a placebo).…”
Section: Treatment Of Liver Cirrhosis In Traditional Chinese Medicinementioning
confidence: 99%
“…Additionally, the incidence of complications such as spontaneous bacterial peritonitis, hepatic encephalopathy, hepatorenal syndrome, gastrointestinal bleeding, and electrolyte imbalance was significantly lower in the combined treatment group. The authors concluded that integrating Chinese medicine and Western medicine in the treatment of cirrhosis can effectively reduce complications, improve clinical symptoms, and enhance clinical efficacy, making it worthy of further research and clinical application ( You et al, 2023 ). In another prospective randomized controlled trial on hepatitis B cirrhosis, it was found that the antiviral entecavir combined with Fuzheng Huayu tablets improved the biochemical response rate and showed trends towards improving HBeAg seroconversion and liver fibrosis rates, compared to the control group (entecavir plus a placebo).…”
Section: Treatment Of Liver Cirrhosis In Traditional Chinese Medicinementioning
confidence: 99%